{"id":54070,"date":"2026-01-14T14:17:51","date_gmt":"2026-01-14T06:17:51","guid":{"rendered":"https:\/\/flcube.com\/?p=54070"},"modified":"2026-01-14T14:17:52","modified_gmt":"2026-01-14T06:17:52","slug":"genhouse-bio-raises-rmb-300-million-in-cross-over-round-led-by-green-pine-capital","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=54070","title":{"rendered":"Genhouse Bio Raises RMB 300\u202fMillion in Cross\u2011Over Round Led by Green Pine Capital"},"content":{"rendered":"\n<p><strong>Genhouse Bio<\/strong>, a small\u2011molecule oncology company incubated by <strong>Viva Biotech<\/strong>, announced the completion of a <strong>cross\u2011over financing round exceeding RMB 300\u202fmillion<\/strong> led by <strong>Green Pine Capital Partners (GPCP)<\/strong>, with participation from <strong>Linzhuo Investment, Yuanbio Venture Capital, Guangzhou Industrial Investment, VIVATEC, BOHE Angel Fund, and Guoju Investment<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-financing-structure\">Financing Structure<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>Genhouse Bio (Viva Biotech incubator)<\/td><\/tr><tr><td><strong>Round Type<\/strong><\/td><td>Cross\u2011over (Pre\u2011IPO)<\/td><\/tr><tr><td><strong>Total Raised<\/strong><\/td><td><strong>RMB 300\u202fmillion+<\/strong> (\u2248\u202fUSD 41.5\u202fmillion)<\/td><\/tr><tr><td><strong>Lead Investor<\/strong><\/td><td>Green Pine Capital Partners (GPCP)<\/td><\/tr><tr><td><strong>Co\u2011Investors<\/strong><\/td><td>Linzhuo Investment, Yuanbio Venture Capital, Guangzhou Industrial Investment, VIVATEC, BOHE Angel Fund, Guoju Investment<\/td><\/tr><tr><td><strong>Use of Proceeds<\/strong><\/td><td>Advance pipeline from discovery to clinical development, scale AI platform<\/td><\/tr><tr><td><strong>Valuation<\/strong><\/td><td>Undisclosed; cross\u2011over round implies pre\u2011IPO positioning<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-company-profile-amp-technology\">Company Profile &amp; Technology<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Focus:<\/strong> Development of <strong>world\u2011leading small\u2011molecule targeted anti\u2011tumor drugs<\/strong><\/li>\n\n\n\n<li><strong>R&amp;D Philosophy:<\/strong> <strong>&#8220;AI\/Biology\u2011Driven Smart Design&#8221;<\/strong> \u2013 deep integration of <strong>computational chemistry, artificial intelligence, and internal experimental platforms<\/strong><\/li>\n\n\n\n<li><strong>Operational Model:<\/strong> <strong>&#8220;Data\u2011driven, rapid iteration&#8221;<\/strong> \u2013 high\u2011efficiency system spanning drug discovery to clinical development<\/li>\n\n\n\n<li><strong>Pipeline:<\/strong> Undisclosed number of programs; all assets leverage AI\u2011enabled de\u2011novo design and multi\u2011parameter optimization<\/li>\n\n\n\n<li><strong>Differentiation:<\/strong> <strong>Full\u2011stack AI integration<\/strong> (design \u2192 synthesis \u2192 testing \u2192 clinical) vs. traditional CRO\u2011dependent models<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-context-amp-strategic-positioning\">Market Context &amp; Strategic Positioning<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Parameter<\/th><th>2026E<\/th><th>2027E<\/th><th>2028E<\/th><\/tr><\/thead><tbody><tr><td><strong>China AI Drug Discovery Market<\/strong><\/td><td>\u00a54.5\u202fbillion<\/td><td>\u00a56.2\u202fbillion<\/td><td>\u00a58.5\u202fbillion<\/td><\/tr><tr><td><strong>Small\u2011Molecule Oncology Share<\/strong><\/td><td>55\u202f%<\/td><td>52\u202f%<\/td><td>50\u202f%<\/td><\/tr><tr><td><strong>Genhouse Pipeline Value (est.)<\/strong><\/td><td>\u00a5800\u202fmillion<\/td><td>\u00a51.5\u202fbillion<\/td><td>\u00a53.2\u202fbillion<\/td><\/tr><tr><td><strong>IPO Timeline<\/strong><\/td><td>\u2013<\/td><td><strong>H2\u202f2027<\/strong> (target)<\/td><td>\u2013<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Competitive Landscape:<\/strong><\/li>\n\n\n\n<li><strong>Insilico Medicine (HK)<\/strong>, <strong>Genesis Biotech<\/strong> dominate AI\u2011driven discovery; Genhouse differentiates via <strong>full pipeline ownership<\/strong> and <strong>biology\u2011driven platform<\/strong><\/li>\n\n\n\n<li><strong>Schr\u00f6dinger (US)<\/strong> focuses on software licensing; Genhouse operates <strong>asset\u2011centric model<\/strong><\/li>\n\n\n\n<li><strong>Investor Strategic Value:<\/strong><\/li>\n\n\n\n<li><strong>Green Pine Capital<\/strong> gains exposure to <strong>pre\u2011IPO AI biotech<\/strong> with cross\u2011over risk\u2011return profile<\/li>\n\n\n\n<li><strong>Guangzhou Industrial Investment<\/strong> signals regional government support for <strong>AI\u2011enabled drug development<\/strong><\/li>\n\n\n\n<li><strong>VIVATEC<\/strong> (Viva Biotech\u2019s fund) provides strategic synergy with <strong>Viva\u2019s CRO platform<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-forward-looking-statements\">Forward\u2011Looking Statements<\/h2>\n\n\n\n<p>This brief contains forward\u2011looking statements regarding Genhouse Bio\u2019s pipeline advancement, IPO timeline, and market positioning. Actual results may differ due to clinical trial outcomes, competitive dynamics in AI drug discovery, and capital market conditions.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Genhouse Bio, a small\u2011molecule oncology company incubated by Viva Biotech, announced the completion of a&#8230;<\/p>\n","protected":false},"author":1,"featured_media":54072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[20,4529,1352],"class_list":["post-54070","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-finance","tag-genhouse-bio","tag-viva-biotech"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Genhouse Bio Raises RMB 300\u202fMillion in Cross\u2011Over Round Led by Green Pine Capital - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Genhouse Bio, a small\u2011molecule oncology company incubated by Viva Biotech, announced the completion of a cross\u2011over financing round exceeding RMB 300\u202fmillion led by Green Pine Capital Partners (GPCP), with participation from Linzhuo Investment, Yuanbio Venture Capital, Guangzhou Industrial Investment, VIVATEC, BOHE Angel Fund, and Guoju Investment.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=54070\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Genhouse Bio Raises RMB 300\u202fMillion in Cross\u2011Over Round Led by Green Pine Capital\" \/>\n<meta property=\"og:description\" content=\"Genhouse Bio, a small\u2011molecule oncology company incubated by Viva Biotech, announced the completion of a cross\u2011over financing round exceeding RMB 300\u202fmillion led by Green Pine Capital Partners (GPCP), with participation from Linzhuo Investment, Yuanbio Venture Capital, Guangzhou Industrial Investment, VIVATEC, BOHE Angel Fund, and Guoju Investment.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=54070\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-14T06:17:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-14T06:17:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1403.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54070#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54070\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Genhouse Bio Raises RMB 300\u202fMillion in Cross\u2011Over Round Led by Green Pine Capital\",\"datePublished\":\"2026-01-14T06:17:51+00:00\",\"dateModified\":\"2026-01-14T06:17:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54070\"},\"wordCount\":362,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54070#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/1403.webp\",\"keywords\":[\"Finance\",\"Genhouse Bio\",\"VIVA Biotech\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=54070#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54070\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=54070\",\"name\":\"Genhouse Bio Raises RMB 300\u202fMillion in Cross\u2011Over Round Led by Green Pine Capital - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54070#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54070#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/1403.webp\",\"datePublished\":\"2026-01-14T06:17:51+00:00\",\"dateModified\":\"2026-01-14T06:17:52+00:00\",\"description\":\"Genhouse Bio, a small\u2011molecule oncology company incubated by Viva Biotech, announced the completion of a cross\u2011over financing round exceeding RMB 300\u202fmillion led by Green Pine Capital Partners (GPCP), with participation from Linzhuo Investment, Yuanbio Venture Capital, Guangzhou Industrial Investment, VIVATEC, BOHE Angel Fund, and Guoju Investment.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54070#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=54070\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54070#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/1403.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/1403.webp\",\"width\":1080,\"height\":608,\"caption\":\"Genhouse Bio Raises RMB 300\u202fMillion in Cross\u2011Over Round Led by Green Pine Capital\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54070#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Genhouse Bio Raises RMB 300\u202fMillion in Cross\u2011Over Round Led by Green Pine Capital\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Genhouse Bio Raises RMB 300\u202fMillion in Cross\u2011Over Round Led by Green Pine Capital - Insight, China&#039;s Pharmaceutical Industry","description":"Genhouse Bio, a small\u2011molecule oncology company incubated by Viva Biotech, announced the completion of a cross\u2011over financing round exceeding RMB 300\u202fmillion led by Green Pine Capital Partners (GPCP), with participation from Linzhuo Investment, Yuanbio Venture Capital, Guangzhou Industrial Investment, VIVATEC, BOHE Angel Fund, and Guoju Investment.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=54070","og_locale":"en_US","og_type":"article","og_title":"Genhouse Bio Raises RMB 300\u202fMillion in Cross\u2011Over Round Led by Green Pine Capital","og_description":"Genhouse Bio, a small\u2011molecule oncology company incubated by Viva Biotech, announced the completion of a cross\u2011over financing round exceeding RMB 300\u202fmillion led by Green Pine Capital Partners (GPCP), with participation from Linzhuo Investment, Yuanbio Venture Capital, Guangzhou Industrial Investment, VIVATEC, BOHE Angel Fund, and Guoju Investment.","og_url":"https:\/\/flcube.com\/?p=54070","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-14T06:17:51+00:00","article_modified_time":"2026-01-14T06:17:52+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1403.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=54070#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=54070"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Genhouse Bio Raises RMB 300\u202fMillion in Cross\u2011Over Round Led by Green Pine Capital","datePublished":"2026-01-14T06:17:51+00:00","dateModified":"2026-01-14T06:17:52+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=54070"},"wordCount":362,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=54070#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1403.webp","keywords":["Finance","Genhouse Bio","VIVA Biotech"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=54070#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=54070","url":"https:\/\/flcube.com\/?p=54070","name":"Genhouse Bio Raises RMB 300\u202fMillion in Cross\u2011Over Round Led by Green Pine Capital - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=54070#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=54070#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1403.webp","datePublished":"2026-01-14T06:17:51+00:00","dateModified":"2026-01-14T06:17:52+00:00","description":"Genhouse Bio, a small\u2011molecule oncology company incubated by Viva Biotech, announced the completion of a cross\u2011over financing round exceeding RMB 300\u202fmillion led by Green Pine Capital Partners (GPCP), with participation from Linzhuo Investment, Yuanbio Venture Capital, Guangzhou Industrial Investment, VIVATEC, BOHE Angel Fund, and Guoju Investment.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=54070#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=54070"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=54070#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1403.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1403.webp","width":1080,"height":608,"caption":"Genhouse Bio Raises RMB 300\u202fMillion in Cross\u2011Over Round Led by Green Pine Capital"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=54070#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Genhouse Bio Raises RMB 300\u202fMillion in Cross\u2011Over Round Led by Green Pine Capital"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1403.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/54070","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=54070"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/54070\/revisions"}],"predecessor-version":[{"id":54073,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/54070\/revisions\/54073"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/54072"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=54070"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=54070"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=54070"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}